Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Lactobacillus</i>-rich cervicovaginal microbiome associated with lower BV, HPV, and cytology outcomes in women.

iScience·2025

Same author

STING Agonist VB-85247 Induces Durable Antitumor Immune Responses by Intravesical Administration in a Non-Muscle-Invasive Bladder Cancer.

Cancer research·2024

Same author

Molecular characterization of vaginal microbiota using a new 22-species qRT-PCR test to achieve a relative-abundance and species-based diagnosis of bacterial vaginosis.

Frontiers in cellular and infection microbiology·2024

Same author

Development and Diagnostic Potential of a Novel Bartonella henselae-Specific Immunoglobulin.

Diagnostic microbiology and infectious disease·2024

Same author

Species-Specific Analysis of Bacterial Vaginosis-Associated Bacteria.

Microbiology spectrum·2023

Same author

High-Risk HPV Genotype Distribution According to Cervical Cytology and Age.

Open forum infectious diseases·2022

Search research articles

Related Experiment Video

Updated: May 27, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

CIP2A expression is elevated in cervical cancer.

Lisa P Huang¹, Martin E Adelson, Eli Mordechai

¹Oncoveda, Tumor Biology Center, Medical Diagnostic Laboratories LLC, A member of Genesis Biotechnology Group, Hamilton, NJ 08690, USA.

Cancer Biomarkers : Section a of Disease Markers

|November 11, 2011

Summary

This summary is machine-generated.

Cancerous inhibitor of protein 2A (CIP2A) shows promise as a biomarker for cervical cancer detection. Elevated CIP2A levels in cervical tissues offer high sensitivity and specificity, potentially improving early diagnosis.

Related Experiment Videos

Last Updated: May 27, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Area of Science:

Oncology
Molecular Biology
Gynecologic Pathology

Background:

Early cervical cancer detection is crucial for patient survival.
Current methods like Pap smears are subjective, and HPV testing lacks predictive power for malignancy.
There is a need for accurate diagnostic tools for cervical cancer.

Purpose of the Study:

To evaluate Cancerous inhibitor of protein 2A (CIP2A) as a potential biomarker for cervical cancer detection.
To compare CIP2A expression with p16INK4a in cervical tissues.
To assess the diagnostic accuracy of CIP2A mRNA and protein levels.

Main Methods:

Quantitative reverse transcription PCR (qRT-PCR) and western blotting were employed.
Expression levels of CIP2A and p16INK4a were analyzed in cervical tumor and adjacent normal tissues.
Patient data including HPV status, age, and race were considered.

Main Results:

CIP2A was highly expressed in cervical cancer cell lines and tumor tissues, but not in normal epithelial cells.
CIP2A mRNA and protein levels were significantly elevated in tumor tissues compared to normal adjacent tissues.
CIP2A mRNA detection showed 80% sensitivity and 91% specificity; protein detection showed 83% sensitivity and 100% specificity.
CIP2A expression did not correlate with HPV infection, age, or race.

Conclusions:

CIP2A is a potential biomarker for sensitive and specific detection of cervical cancer.
CIP2A expression levels are comparable to p16INK4a in diagnostic accuracy.
Further large-scale prospective studies are warranted to validate CIP2A as a reliable biomarker.